BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17123350)

  • 1. Artifactual I-131 activity in the hairs after thyroid remnant ablation.
    Bhargava P; Choi WS
    Thyroid; 2006 Nov; 16(11):1187-9. PubMed ID: 17123350
    [No Abstract]   [Full Text] [Related]  

  • 2. Exercise-induced radio-iodine accumulation in scalp and hair during admission of 131I therapy for thyroid cancer.
    Zakavi SR; Kakhki VD
    Thyroid; 2006 Nov; 16(11):1185-6. PubMed ID: 17123349
    [No Abstract]   [Full Text] [Related]  

  • 3. Esophageal diverticulum presenting as metastatic thyroid mass on iodine-131 scintigraphy.
    Rashid K; Johns W; Chasse K; Walker M; Gupta SM
    Clin Nucl Med; 2006 Jul; 31(7):405-8. PubMed ID: 16785810
    [No Abstract]   [Full Text] [Related]  

  • 4. [Iodine scintigraphy of differentiated thyroid carcinoma].
    Nakata K; Tsukamoto E; Ito K; Kato C; Furudate M
    Rinsho Hoshasen; 1988 May; 33(5):589-90. PubMed ID: 3047462
    [No Abstract]   [Full Text] [Related]  

  • 5. Retention of iodine-131 in respiratory tract in a patient with papillary thyroid carcinoma after radionuclide therapy: a rare false-positive finding.
    Kienast O; Hofmann M; Ozer S; Dobrozemsky G; Dudczak R; Kurtaran A
    Thyroid; 2003 May; 13(5):509-10. PubMed ID: 12855020
    [No Abstract]   [Full Text] [Related]  

  • 6. Partial stunning in thyroid remnant after administration of scanning dose followed by 100 mCi I-131 therapy.
    Yagcloglu H; Ozalp E; Ibis E; Aras G
    Clin Nucl Med; 1996 Apr; 21(4):340. PubMed ID: 8925630
    [No Abstract]   [Full Text] [Related]  

  • 7. Stunning with 131I diagnostic whole-body imaging of patients with thyroid cancer.
    Gerard SK; Dam HQ
    Radiology; 2005 Mar; 234(3):972-3; author reply 973-4. PubMed ID: 15734947
    [No Abstract]   [Full Text] [Related]  

  • 8. Thyroid remnant ablation in patients with papillary cancer: a comparison of low, moderate, and high activities of radioiodine.
    Kusacic Kuna S; Samardzic T; Tesic V; Medvedec M; Kuna K; Bracic I; Despot M; Dodig D
    Nucl Med Commun; 2009 Apr; 30(4):263-9. PubMed ID: 19247212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid carcinoma metastatic to pituitary.
    Sziklas JJ; Mathews J; Spencer RP; Rosenberg RJ; Ergin MT; Bower BF
    J Nucl Med; 1985 Sep; 26(9):1097. PubMed ID: 4032051
    [No Abstract]   [Full Text] [Related]  

  • 10. False positive and false negative thyroid 99mTc-sestamibi scintigraphy in the same patient.
    Gholamrezanezhad A; Muckle M; Ahmadzadehfar H; Biersack HJ; Ezziddin S
    Nuklearmedizin; 2010; 49(6):N69-70. PubMed ID: 21140034
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of outcomes after (123)I versus (131)I pre-ablation imaging before radioiodine ablation in differentiated thyroid carcinoma.
    Silberstein EB
    J Nucl Med; 2007 Jul; 48(7):1043-6. PubMed ID: 17574976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iodine 131 uptake related to hair dyeing.
    Meyers A; Harry L; Peterson B
    Radiol Technol; 2007; 78(5):433-4. PubMed ID: 17519382
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of low-dose iodine-131 ablation of post-operative thyroid remnants: a study of 69 cases.
    Leung SF; Law MW; Ho SK
    Br J Radiol; 1992 Oct; 65(778):905-9. PubMed ID: 1422665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual extrathyroidal iodine accumulation in a post-ablative I-131 scan.
    McEwan LM; Fong W
    Australas Radiol; 2001 Nov; 45(4):512-3. PubMed ID: 11903188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 131I treatment of thyroid papillary carcinoma in a patient with renal failure.
    Morrish DW; Filipow LJ; McEwan AJ; Schmidt R; Murland KR; von Westarp C; Betcher KB
    Cancer; 1990 Dec; 66(12):2509-13. PubMed ID: 2249192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-stunning in thyroid ablation: evidence from comparative studies of diagnostic 131I and 123I.
    Hilditch TE; Dempsey MF; Bolster AA; McMenemin RM; Reed NS
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):783-8. PubMed ID: 12029552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow-up regimen of differentiated thyroid carcinoma in thyroidectomized patients after thyroid hormone withdrawal.
    Oyen WJ; Verhagen C; Saris E; van den Broek WJ; Pieters GF; Corsten FH
    J Nucl Med; 2000 Apr; 41(4):643-6. PubMed ID: 10768565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. False positive uptake in post-treatment iodine-131 whole-body scans secondary to contamination.
    Schlosser J; Paliou M; Bravo-Vera R; Sheikh A; Gouller A
    Thyroid; 2007 Jan; 17(1):81-2. PubMed ID: 17274756
    [No Abstract]   [Full Text] [Related]  

  • 19. Visualization of the thymus with therapeutic doses of radioiodine in patients with thyroid cancer.
    Michigishi T; Mizukami Y; Shuke N; Yokoyama K; Noguchi M; Watanabe Y; Matsui O; Aburano T; Tonami N; Hisada K
    Eur J Nucl Med; 1993 Jan; 20(1):75-9. PubMed ID: 8267685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unusual radioiodine uptake caused by metallic sutures in the skull in a patient with thyroid cancer.
    Modoni S; Martino G; Guerra M; Frusciante V
    Clin Nucl Med; 2000 Dec; 25(12):1053-4. PubMed ID: 11129153
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.